BIORESTORATIVE THERAPIES, INC. Chart calendar BioRestorative Therapies, Inc.
dba78a1b952c97aaad0c03cb8.uLryTKziW55ml3LT98WiwVhEAgbHHpuSgb8rx8ISaIo._eKmI5-jMfxSyCqyprCXpTYsSVb0StH06Y1bvZoiEdvt8IgNnrgK8h6kFQ~602fcc0df47522f667d12766d2f0f85c
Upcoming events on BioRestorative Therapies, Inc.
No events available
Past events on BioRestorative Therapies, Inc.
| 2024-03-18 03:00 pm | Roth Conference |
| 2024-02-05 08:30 am | BRTX-100 Phase 2 Clinical Trial Results Call |
| 2024-02-04 01:15 pm | Orthopaedic Research Society Meeting |
| 2023-10-14 09:00 am | ROTH MKM Healthcare Opportunities Conference |
| 2023-09-13 10:00 am | Annual General Meeting |
| 2023-06-22 09:30 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-06 | Jefferies Global Healthcare Conference |
| 2023-05-09 | EF Hutton Global Conference |
| 2023-03-11 | Roth Conference |
| 2023-01-26 10:30 am | Q1 Investor Summit |
| 2022-12-05 10:00 am | RHK Capital Disruptive Growth Conference |
| 2022-10-11 | Dawson James Small Cap Growth Conference |
| 2022-10-05 | Roth Healthcare Opportunities Conference |
| 2022-09-14 11:30 am | H.C. Wainwright Global Investment Conference |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference - Pre-Recorded |
| 2021-08-17 10:00 am | Annual General Meeting |
| 2021-06-09 10:45 am | The Emerging Growth Conference |
| 2018-05-15 05:49 pm | Q1 2018 Earnings Release |
| 2017-06-15 10:30 am | Nasdaq Investor Program |
| 2016-06-02 10:30 am | Marcum MicroCap Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,08 | 0,05 0,04 12.2% | 0,12 0,13 -8.55% | 0,15 0,14 2.68% | 0,06 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -26,3 -24,2 -8.72% | -19,0 -19,3 1.52% | -15,2 -15,3 0.28% | -17,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -44,3 -24,0 -84.6% | -18,5 -19,1 3.28% | -14,4 -14,8 2.62% | -17,6 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -44,3 -25,8 -71.72% | -18,5 -19,1 3.28% | -14,4 -14,8 2.62% | -17,6 |
|
EPS USD | Released Forecast Spread | -0,01 | -37,3 -5,54 -573.29% | -5,11 -5,28 3.22% | -3,42 -3,52 2.84% | -2,13 |
| Announcement Date | 30/04/21 | 30/03/22 | 27/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,01 0,00 - | 0,02 0,00 - | 0,03 0,00 - | 0,00 0,02 -75.33% | 0,03 0,03 4.33% | 0,06 0,02 330% | 0,03 0,02 104.67% | 0,02 0,02 28.67% | 0,03 | 0,03 | 0,03 | 0,03 |
|
EBIT Million USD | Released Forecast Spread | -4,01 -1,90 -111.01% | -5,05 -2,25 -124.61% | -4,61 -5,27 12.58% | -4,68 -4,97 5.87% | -5,78 -4,83 -19.75% | -3,12 -5,95 47.63% | -3,10 -3,27 5.06% | -3,22 -3,26 1.3% | -3,51 | -3,94 | -4,48 | -5,17 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,66 -5,27 11.7% | -4,35 -4,97 12.59% | -5,68 -4,73 -20.28% | -2,98 -5,90 49.49% | -2,93 -3,17 7.71% | -2,83 -3,21 12.07% | -3,41 | -3,84 | -4,38 | -5,07 | ||
|
Net income Million USD | Released Forecast Spread | -20,4 -1,90 -973.85% | -4,82 -2,25 -114.05% | -4,66 -5,27 11.7% | -4,35 -4,97 12.59% | -5,68 -4,73 -20.28% | -2,98 -5,90 49.49% | -2,93 -3,17 7.71% | -2,83 -3,21 12.07% | -3,41 | -3,84 | -4,38 | -5,07 |
|
EPS USD | Released Forecast Spread | -6,99 -0,54 -1194.44% | -1,37 -0,63 -117.46% | -1,28 -1,45 11.72% | -1,18 -1,35 12.59% | -1,53 -1,26 -21.43% | -0,77 -1,19 35.29% | -0,64 -0,68 5.88% | -0,57 -0,69 17.39% | -0,51 | -0,46 | -0,52 | -0,48 |
| Announcement Date | 30/03/22 | 16/05/22 | 14/11/22 | 27/03/23 | 12/05/23 | 11/08/23 | 13/11/23 | 01/04/24 | - | - | - | - |
More events
